TriSalus Life Sciences, Inc. Preferred Stock Convertible Down Round Feature Increase Decrease In Equity Amount1
TriSalus Life Sciences, Inc. (TLSI) reported Preferred Stock Convertible Down Round Feature Increase Decrease In Equity Amount1 of $0 for the 12-month period ending 2023-12-31, per its 10-K/A filed 2025-05-30.
Financial Statements › Shareholders' Equity
us-gaap:PreferredStockConvertibleDownRoundFeatureIncreaseDecreaseInEquityAmount1 · last filed 2025-05-30
- TriSalus Life Sciences, Inc. preferred stock convertible down round feature increase decrease in equity amount1 for the quarter ending 2023-06-30 was $0.00.
- TriSalus Life Sciences, Inc. preferred stock convertible down round feature increase decrease in equity amount1 for the quarter ending 2023-03-31 was $0.00.
- TriSalus Life Sciences, Inc. preferred stock convertible down round feature increase decrease in equity amount1 for fiscal 2023 was $0.00.
- TriSalus Life Sciences, Inc. preferred stock convertible down round feature increase decrease in equity amount1 for fiscal 2022 was $0.00.
| Period end | Preferred Stock Convertible Down Round Feature Increase Decrease In Equity Amount1 3 month | Preferred Stock Convertible Down Round Feature Increase Decrease In Equity Amount1 6 month | Preferred Stock Convertible Down Round Feature Increase Decrease In Equity Amount1 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 10-K/A · filed 2025-05-30 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-11-14 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |